Microglia inhibitor stops neuronal cell death after TBI
Targeting overactive immune cells in the brain and dampening their chronic neurotoxic effects may offer a new therapeutic strategies for traumatic...
Roche gets FDA okay for COVID-19 antibody test
The US Food and Drug Administration has granted Emergence use approval (EUA) to Roche Diagostics GmbH’s new Elecsys® Anti-SARS-CoV-2 antibody...
Post-Brexit budget drives cuts in Horizon Europe
Eying the Brexit, the European Commission and Member States have to handle a reduction in the EU’s next seven-year bugdet of €75bn (2021–2027)....
Vaccine to protect from any viral infection
In contrast to all current vaccination approaches against SARS-Co-V-2, the approach of Mirror Biologics Inc., the US subsidiary of Jerusalem-based...
4Teen4’s DPP3 predicts burn mortality
High blood concentrations of a biomarker, previously described as indicator of massive cell death and inflammation, has been shown to be associated...
COVID-19: Novartis starts study on hyped malaria drug
Cardiologists have red-flagged combination therapies of cloroquine phosphate (Resochin, Bayer AG, Germany) or hydroxychloroquine (Novartis AG, Basel)...
Novacyt inks contract on Covid-19 diagnostics
Novacyt SA ’s British molecular diagnostics division Primerdesign Ltd (Camberley) signed a global distribution agreement for its COVID-19 test with...